相关实验视频
Updated: Aug 15, 2026

12:13
Ex Situ Normothermic Machine Perfusion of Donor Livers
Published on: May 26, 2015
11.6K
2050年的外科周周流体和血管压力疗法:从实验医学到通过自动化实现个性化
Sean Coeckelenbergh1,2, Jean-Louis Vincent3, Jacques Duranteau1,4
1From the Department of Anesthesiology and Intensive Care, Hôpitaux Universitaires Paris-Saclay, Université Paris-Saclay, Hôpital Paul-Brousse, Paris, France.
Anesthesia and analgesia
|January 12, 2024
概括
静脉注射 (IV) 液体和血管压缩剂对于血液动力学管理至关重要. 未来的自动化,由人工智能驱动,有望通过计算机辅助的治疗管理来增强术后护理.
科学领域:
- 麻醉学和重症监护医学
- 心血管生理学心血管生理学
- 医疗技术和自动化
背景情况:
- 静脉注射 (IV) 流体治疗和血管压力剂是血液动力学管理的基础,其历史可以追溯到19世纪.
- 由于静脉接入,连续输液能力和复杂的血液动力学监测设备的进步,管理和监测的早期限制已经被克服.
- 监测的演变,从肺动脉导管到不那么侵入性的技术,如声谱和脉冲轮分析,已经改进了这些疗法的应用.
结论:
- 集成先进的监测和计算机辅助,特别是人工智能,即将彻底改变外科手术期间的血液动力学管理.
- 未来的自动化有可能实现更精确,更快速,更高效的IV液体和血管压缩剂的管理.
- 医疗技术的持续创新可能会导致在外科手术环境中完全自动化的血液动力学管理系统.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

